| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |